Position in IRWD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$52,748,280
-$1,255,970 QoQ
Shares Held
15,028,000
-6.2% QoQ
Ownership
9.13%
of shares outstanding
% of Portfolio
1.75%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IRWD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $281,938,279 across 8 Drug Manufacturers - Specialty & Generic names. IRWD ranks #3 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
1,895,347 | $97,970,486 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
724,000 | $95,379,760 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
This page
|
15,028,000 | $52,748,280 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,909,838 | $11,077,060 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
3,930,125 | $10,768,542 | |
| 6 | EOLS |
Evolus, Inc.
|
1,396,000 | $5,737,560 | |
| 7 | CTOR |
Citius Oncology, Inc.
|
9,188,855 | $5,697,090 | |
| 8 | BTAI |
BioXcel Therapeutics, Inc.
|
1,910,076 | $2,559,501 |
All Filings in IRWD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,748,280 | 15,028,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $54,004,250 | 16,025,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,156,500 | 16,150,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $11,628,000 | 16,150,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $20,139,000 | 13,700,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $41,943,240 | 9,468,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,784,000 | 8,200,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $50,856,000 | 7,800,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $47,034,000 | 5,400,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $65,208,000 | 5,700,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $33,281,280 | 3,456,000 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||